HI
CELG

HBK Investments’s Celgene Corp CELG Stock Holding History

HBK Investments’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-15,825,800
Closed -$1.57B – 803
2019
Q3 		$1.57B Buy
+15,825,800
New +$1.5B 20.09% 1
2019
Q2 		– Sell
-3,315,100
Closed -$313M – 1231
2019
Q1 		$313M Buy
+3,315,100
New +$290M 3.16% 5
2018
Q3 		– Sell
-15,550,600
Closed -$1.37B – 1461
2018
Q2 		$1.44B Buy
+15,550,600
New +$1.29B 9.43% 2
2018
Q1 		– Sell
-89,634
Closed -$9.35M – 1246
2017
Q4 		$9.35M Buy
+89,634
New +$10.1M 0.07% 163
2017
Q3 		– Sell
-104,109
Closed -$13.5M – 1217
2017
Q2 		$13.5M Buy
+104,109
New +$12.8M 0.08% 125
2016
Q4 		– Sell
-27,960
Closed -$2.92M – 989
2016
Q3 		$2.92M Sell
27,960
-14,015
-33% -$1.52M 0.03% 296
2016
Q2 		$4.14M Buy
+41,975
New +$4.34M 0.03% 271
2013
Q3 		– Sell
-34,328
Closed -$2.01M – 1050
2013
Q2 		$2.01M Buy
+34,328
New +$2.07M 0.03% 262

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $8.4B AUM 51.89% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

HBK Investments's CELG Position: Q4 2019 in Review

HBK Investments sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 15,825,800 shares — an estimated $1.57B sold.

HBK Investments first reported a position in CELG in Q2 2013 and held it in 8 quarters. The position peaked at $1.57B in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • HBK Investments reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • HBK Investments sold 15,825,800 Celgene Corp shares in Q4 2019, an estimated $1.57B.
  • HBK Investments first reported a position in Celgene Corp in Q2 2013 and held it in 8 quarters.
  • HBK Investments's Celgene Corp position peaked at $1.57B in Q3 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on HBK Investments's 13F filing for Q4 2019, filed 14 Feb 2020.